<ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from (a) Gelman Sciences Inc. Statement of Operations and Consolidated Statement of Cash Flow for the twelve months ended July 31, 1995 and the Consolidated Balance Sheet as of July 31, 1995 and is qualified in its entirety by reference to such (b) Form 10-K for the fiscal year ended July 31, 1995. </LEGEND> <PERIOD-TYPE> Year <FISCAL-YEAR-END> JUL-31-1995 <PERIOD-END> JUL-31-1995 <CASH> 3,010 <SECURITIES> 0 <RECEIVABLES> 23,985 <ALLOWANCES> 1,310 <INVENTORY> 14,944 <CURRENT-ASSETS> 46,927 <PP&E> 69,842 <DEPRECIATION> 37,258 <TOTAL-ASSETS> 81,781 <CURRENT-LIABILITIES> 15,017 <BONDS> 5,493 <COMMON> 779 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 57,994 <TOTAL-LIABILITY-AND-EQUITY> 81,781 <SALES> 103,503 <TOTAL-REVENUES> 103,503 <CGS> 50,070 <TOTAL-COSTS> 50,070 <OTHER-EXPENSES> 41,568 <LOSS-PROVISION> 564 <INTEREST-EXPENSE> 1,314 <INCOME-PRETAX> 9,987 <INCOME-TAX> 3,365 <INCOME-CONTINUING> 6,622 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 6,622 <EPS-PRIMARY> .92 <EPS-DILUTED> .92